Genesis Biopharma, a biotechnology company developing targeted cancer therapies, note that Patrick Hwu, M.D., and Mario Sznol, M.D., have joined the company's recently formed scientific and medical advisory board.

Hwu is currently faculty at the University of Texas MD Anderson Cancer Center in Houston, and serves as chairman of the Center's Department of Melanoma Medical Oncology, Division of Cancer Medicine.

Sznol is currently faculty at Yale University School of Medicine, is a Professor of Medicine (Medical Oncology), and also serves as vice-chief medical oncology and co-director of the Yale Cancer Center Melanoma Program.